Sa
Non vérifié

Santhera Pharmaceuticals Holding AG

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologiePublicité/Marketing/Médias/Communication
04/11/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Closes USD 13 Million Royalty Monetization Agreement
1.00
08/10/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia
1.00
02/10/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
1.00
24/09/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Provides Update on Convertible Bond Issued on 23 September 2025
1.00
22/09/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update
1.00
22/09/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update
1.00
22/09/2025
Biotechnologie
Publicité/Marketing/Médias/Communication
Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE® Rollout
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0